125 related articles for article (PubMed ID: 31867792)
21. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications.
Yamaguchi R; Horii R; Maeda I; Suga S; Makita M; Iwase T; Oguchi M; Ito Y; Akiyama F
Hum Pathol; 2010 May; 41(5):679-85. PubMed ID: 20153509
[TBL] [Abstract][Full Text] [Related]
23. Metaplastic breast carcinoma on fine-needle cytology samples: a report of three cases.
Fulciniti F; Mansueto G; Vetrani A; Accurso A; Fortunato A; Palombini L
Diagn Cytopathol; 2005 Sep; 33(3):205-9. PubMed ID: 16078244
[TBL] [Abstract][Full Text] [Related]
24. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.
Bartels S; van Luttikhuizen JL; Christgen M; Mägel L; Luft A; Hänzelmann S; Lehmann U; Schlegelberger B; Leo F; Steinemann D; Kreipe H
J Pathol; 2018 Jul; 245(3):373-383. PubMed ID: 29708279
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
26. [Sarcomatoid (metaplastic) spindle cell carcinoma arising in a phylloid tumor with massive squamous metaplasia - a case report and review of the literature].
Kinkor Z; Sticová E; Sach J; Rychtera J; Skálová A
Cesk Patol; 2012 Jul; 48(3):156-60. PubMed ID: 23057431
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
Pareja F; Toss MS; Geyer FC; da Silva EM; Vahdatinia M; Sebastiao APM; Selenica P; Szatrowski A; Edelweiss M; Wen HY; Mihai R; Varga Z; Foschini MP; Rubin BP; Ellis IO; Chandarlapaty S; Jungbluth AA; Brogi E; Weigelt B; Reis-Filho JS; Rakha EA
Histopathology; 2020 May; 76(6):865-874. PubMed ID: 31887226
[TBL] [Abstract][Full Text] [Related]
28. Analysis of metaplastic breast carcinoma: FNAC; histopathology and immunohistochemistry are complementary for diagnosis.
Abd El Hafez A; Shawky Ael-A
Breast Dis; 2013 Jan; 34(2):67-75. PubMed ID: 24077354
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological features of metaplastic breast carcinoma.
Hasdemir OA; Tokgöz S; Köybaşıoğlu F; Karabacak H; Yücesoy C; İmamoğlu Gİ
Adv Clin Exp Med; 2018 Apr; 27(4):509-513. PubMed ID: 29558027
[TBL] [Abstract][Full Text] [Related]
30. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
[TBL] [Abstract][Full Text] [Related]
31. Toker cells of the nipple are commonly associated with underlying sebaceous glands but not with lactiferous ducts.
Saeed D; Shousha S
J Clin Pathol; 2014 Nov; 67(11):1010-2. PubMed ID: 25086135
[TBL] [Abstract][Full Text] [Related]
32. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression.
Barnes PJ; Boutilier R; Chiasson D; Rayson D
Breast Cancer Res Treat; 2005 May; 91(2):173-8. PubMed ID: 15868445
[TBL] [Abstract][Full Text] [Related]
33. Metaplastic carcinoma of the breast: fine-needle aspiration cytology of seven cases.
Stanley MW; Tani EM; Skoog L
Diagn Cytopathol; 1989; 5(1):22-8. PubMed ID: 2721350
[TBL] [Abstract][Full Text] [Related]
34. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
[TBL] [Abstract][Full Text] [Related]
36. Exuberant Squamous Metaplasia with Calcification Following Intraoperative Radiotherapy for Breast Carcinoma: Report of an Unusual Case and Retrospective Review of Cases from a Single Institution.
Ginter PS; Ng J; Zhuo R; Swistel AJ; D'Alfonso TM
Breast J; 2017 May; 23(3):267-274. PubMed ID: 27900811
[TBL] [Abstract][Full Text] [Related]
37. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract][Full Text] [Related]
38. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components.
Wang X; Mori I; Tang W; Yang Q; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kennichi K
Mod Pathol; 2001 Nov; 14(11):1183-6. PubMed ID: 11706082
[TBL] [Abstract][Full Text] [Related]
39. Matrix-producing metaplastic breast carcinoma - a rare tumor with heterologous elements.
Shruti S; Siraj F
Ger Med Sci; 2017; 15():Doc17. PubMed ID: 29255401
[TBL] [Abstract][Full Text] [Related]
40. Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence.
Gobbi H; Simpson JF; Borowsky A; Jensen RA; Page DL
Cancer; 1999 May; 85(10):2170-82. PubMed ID: 10326695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
